Moneycontrol PRO
HomeNewsBusinessMarkets‘Allocate 30%-40% of investable corpus now at the current levels and rest on declines’

‘Allocate 30%-40% of investable corpus now at the current levels and rest on declines’

In our opinion, it is an excellent time to build a long term portfolio as many fundamentally sound counters are available at a good bargain, says Gurpreet Sidana.

April 13, 2020 / 12:39 IST
For those looking to build a fresh portfolio, we would suggest allocating 30-40 percent of their investable corpus at the current levels and wait for further correction or clarity over the market direction, Gurpreet Sidana, Chief Operating Officer, Religare Broking Ltd, said in an interview with Moneycontrol’s Kshitij Anand.
edited excerpts: Q) What is be your advice to investors now - lump sum or staggered approach in direct equities or mutual funds? A) It is a tough situation, not only for the Indian economy but for the markets across the globe. It’s different from earlier downturns as it is triggered by a pandemic and the exact impact or peak can’t be quantified yet. However, this is also true that the market emerges much stronger and garners exceptional returns for those who utilise these corrections to accumulate quality companies with a long-term investment horizon. Maybe a first-timer is still contemplating over his investment plan but a smart investor knows this well and will thus try to exploit this opportunity. Now, coming to the choice of instrument or mode of investment, it is completely personal, depending on the risk profile of the individual. In our opinion, it is an excellent time to build a long term portfolio as many fundamentally sound counters are available at a good bargain. At the same time, you may let your mutual fund SIP running, to take advantage of averaging at lower levels. For those looking to build a fresh portfolio, we would suggest allocating 30-40 percent of their investable corpus at the current levels and wait for further correction or clarity over the market direction. Pharma, FMCG and private bank stocks are preferred bets while SIP in largecap funds and sectoral funds (beaten-down sectors such as Auto, Banks, and Oil & Gas) are advisable.
Q) We have already seen a big casualty in the form of IndiaNivesh Securities broking arm shutting down the operations. Do you think this could just be the starting?

A) Undoubtedly, the current times are challenging and businesses across levels are feeling the heat. Profitability will get hit in these tough times and I am sure most businesses are searching for a way to stay afloat.

In line with the others, some of the brokerage firms, which were already in financial stress, are worst hit due to liquidity crunch after COVID -19 lockdown.

But, I do not see the situation being so grim. We see most of the leading players are on course the journey of transformation and the lockdown period is only helping to cover the distance fast. However, consolidation in the industry is inevitable as there isn’t enough space for too many players.

Q) A lot has been said about COVID-19 hotspots – but where are the hotspots in terms of investment in the current scenario?

A) Given the current situation, few essential consumer products and healthcare products are in high demand as it helps consumers to sail through difficult times. Both FMCG and healthcare sectors are hotspots wherein consistent buying is seen amid coronavirus scare.

We believe these two defensive sectors are safe bets in such volatile markets. Although these sectors are also facing challenges due to lockdown wherein factories are either closed or working with less manpower and supply chains have been hit.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

However, once things begin to recover, there is a likelihood that these sectors would witness a stronger demand for essential items. In the current situation, investors can accumulate stocks from these sectors in a staggered manner for the long term.

Q) What is your take on the ESG sector? Do you think companies in the ESG space could get attention?

A) The ESG space companies take into account the non-financial performance indicators that include environmental, social and corporate governance factors.

These parameters are usually used by socially conscious investors to screen securities to invest. It may offer a potential long-term performance advantage when integrated into investment analysis and portfolio construction.

In India, the ESG based investing is not as big as compared to some of the developed countries. And, companies following the ESG matrix would also face the brunt of a slowdown and that would impact their earnings trajectory. However, their recovery could be comparatively stronger once we see the revival of the economy.

Q) What is your expectations from the FY21? What are your views on earnings, markets, flows, as well as demand?

A) We do not expect a very promising start for FY21 as we are still grappling with the pandemic which has hit economic activity across the globe. We believe Q1 of FY21E will be majorly impacted by the nationwide lockdown, which will lead to earnings downgrade for most of the companies.

Also, FIIs may continue to be net sellers if the situation does not improve in the coming days. Adding to the worries, if the virus spread intensifies further or continues for longer than excepted, it could also induce redemption pressure and that in turn would trigger selling from the DIIs as well.

Nevertheless, Nifty P/E now hovers around its historical average, which provides a good investment opportunity and the past trend suggests that every major fall is followed by a strong rebound in the markets.

Hence, as and when the coronavirus cases start receding, we could see a gradual recovery in demand and pick up in the economy, which would lead to an increase in fund flows to the markets.

Q) In the post-COVID-19 world, what will be the new normal which the world will be looking at in investments, insurance, food habits, consumption, etc.?

A) We may see investors taking the concept of valuation more seriously and plan their future investments accordingly. Also, they might have realised by now the importance of having defensive stocks in their portfolio as a hedge, to sail through the tough time.

Further, the unexpected rise in cases of coronavirus only reinstates the fact that insurance is a necessity and not a discretionary spend and therefore we could see an increase in insurance penetration in India.

Additionally, the consumption would pick up. However, it would be gradual especially for discretionary goods and services.

Q) We have seen massive wealth erosion in most of the top-quality stocks in FY20, and as we step into FY21 some of those names could give multibagger returns if someone is investing in them now. Could you highlight 3-5 such stocks that hold that potential?

A) The Indian markets have corrected sharply from their peaks and we have seen massive wealth erosion in most of the top-quality stocks as growth and earnings for FY21E are expected to get adversely impacted.

Also, with a change in the market dynamics, we could see a change in the sectoral allocation by the fund managers to stay relevant.

Amid all, we believe there are quite a few top names that are trading either close to or below their historical average P/E and provide a margin of safety at current levels.

We recommend accumulating stocks like ICICI Bank, Hindustan Unilever (HUL), Cipla, Reliance Industries and HDFC Life Insurance gradually for healthy long term gains.

Q) Any particular sector(s) which investors should go underweight on at least for the next year or in the current FY?

A) Among the sectors, PSU Banking, metal, realty and auto are affected more by the virus-led economic disruption and thus recovery in these sectors will be gradual.

We would advise investors to stay away from these sectors (at least for the next 2 quarters) or take selective bets until there are meaningful signs of revival.

On the flip side, we are overweight on FMCG, pharma and selective names in private banking as they are already witnessing buying interest or showing resilience at the higher levels and would rebound faster once the economy recovers.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Kshitij Anand
Kshitij Anand is the Editor Markets at Moneycontrol.
first published: Apr 13, 2020 12:39 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347